Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Natus Medical Incorporated - news published 24 - readings 722

BACK

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investmen ...

06.01.2022

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

06.01.2022

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

06.01.2022

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

05.01.2022

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

13.12.2021

Natus Medical Incorporated

Quarterly Report (Form 10-Q)

ntus-20210930 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ...

05.11.2021

Natus Medical Incorporated

Natus Medical Announces Third Quarter 2021 Financial Results - Form 8-K

Natus Medical Announces Third Quarter 2021 Financial Results Q3-2021 Key Results Revenue (millions) $113.9 Ø Revenue increased 11% compared to Q3 2020 Ø Generated $7.1 million in operating cash flow GAAP EPS $0.16 Non-GAAP EPS $0.28 PLEASANTON, Calif. (November 4, 2021) - Natus Medical Incorporated (NASDAQ:NTUS) (the "Company" or "Natus"), a leading provi ...

04.11.2021

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Natus Medical Incorporated published this content on 05 October 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 05 October 2021 21:05:11 UTC .

05.10.2021

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Natus Medical Incorporated published this content on 20 August 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 20 August 2021 20:43:20 UTC .

20.08.2021

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Natus Medical Incorporated published this content on 20 August 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 20 August 2021 20:43:17 UTC .

20.08.2021

Natus Medical Incorporated

Initial Insider Trading Report (SEC Filing - 3)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Natus Medical Incorporated published this content on 20 August 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 20 August 2021 20:32:12 UTC .

20.08.2021

Natus Medical Incorporated

Initial Insider Trading Report (SEC Filing - 3)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Natus Medical Incorporated published this content on 20 August 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 20 August 2021 20:32:11 UTC .

20.08.2021

Natus Medical Incorporated

Quarterly Report (SEC Filing - 10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file ...

06.08.2021

Natus Medical Incorporated

Natus Chairperson Dr. Barbara Paul Retires; Board Elects Current Board Member Joshua Levine as Chairperson (Form 8-K)

Natus Chairperson Dr. Barbara Paul Retires; Board Elects Current Board Member Joshua Levine as Chairperson PLEASANTON, Calif. (June 28, 2021) - Natus Medical Incorporated (NASDAQ:NTUS) (the 'Company' or 'Natus'), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today ...

29.06.2021

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Natus Medical Incorporated published this content on 21 June 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 21 June 2021 21:25:26 UTC .

21.06.2021

Natus Medical Incorporated - news published 24 - readings 722

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

Natus Medical Incorporated

Statement of Changes in Beneficial Ownership (Form 4)

Natus Medical Incorporated

Quarterly Report (Form 10-Q)

Natus Medical Incorporated

Natus Medical Announces Third Quarter 2021 Financial Results - Form 8-K

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

Natus Medical Incorporated

Initial Insider Trading Report (SEC Filing - 3)

Natus Medical Incorporated

Initial Insider Trading Report (SEC Filing - 3)

Natus Medical Incorporated

Quarterly Report (SEC Filing - 10-Q)

Natus Medical Incorporated

Natus Chairperson Dr. Barbara Paul Retires; Board Elects Current Board Member Joshua Levine as Chairperson (Form 8-K)

Natus Medical Incorporated

Insider Trading Report (SEC Filing - 4)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member